Studies on the role of vitamin K on breast cancer are conflicting and vary between different forms of vitamin K. in vitro and in vivo studies showed that vitamin K2 (menaquinone-4) and vitamin K3 (menadione) have anticancer effects against triple-negative breast cancer (TNBC) and Her2+ breast cancer cells (57). Here, ERBB2 is linked to triple-negative breast carcinoma.